Tamoxifen Citrate
Inquiry
| Post Date: | Oct 24,2015 |
| Expiry Date: | Apr 21,2016 |
| Detailed Description: |
Cas No. :54965-24-1
Tamoxifen Citrate Anti-estrogen Nolvadex Raw Powder
Quick Detail: Synonyms: kessar; noltam; tamofen CAS: 54965-24-1 EINECS: 259-415-2 Assay: 99%-101%. USP31 MF: C32H37NO8 MW: 563.64 Character: White crystalline powder. MP 140-144 degrees 1. Nolvadex is not an anabolic steroid but is used to manage side effects from steroids. 2. Nolvadex is a mixed estrogen agonist/antagonist of the same type as Clomid. 3. Tamoxifen Citrate is the raw material of Nolvadex. 4. Nolvadex is also a kind of medicine to treat cancer. 5. Nolvadex (tamoxifen citrate) is very comparable to Clomid. 6. Nolvadex behaves in the same manner in all tissues with Clomid. Description: Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid. The two molecules are also very similar in structure. It is not correct that Nolvadex reduces levels of estrogen: rather, it blocks estrogen from estrogen receptors and, in those tissues where it is an antagonist, causes the receptor to do nothing. The claim that Nolvadex reduces gains should not be taken too seriously. The fact is that any number of bodybuilders have made excellent gains while using Nolvadex. The belief that it reduces gains seems to stem from the fact that the scientific literature reports a slight reduction in IGF-1 (individuals using anabolic steroids were not studied though) from use of Nolvadex. Thus, Dan Duchaine reported that it reduces IGF-1 and therefore reduces gains. However, if this effect exists at all, it must be very minor, due to the excellent gains that many have made, and from the fact that no one has noticed any such thing from Clomid, which has the same activity profile. The fact that Nolvadex will reduce water retention may result in the user agreeing that gains are less, since weight gain is less, thus reinforcing the bias. Applications: For the treatment of advanced, recurrent breast cancer and ovarian cancer and other illnesses. Used as an antineoplastic raw materials. Biological Activity: Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30. |
| CAS Registry Number: | 54965-24-1 |
| Synonyms: | ;(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;Tamoxiphen Citrate;2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt); |
| Molecular Formula: | C32H34NO8 |
| Molecular Weight: | 560.6159 |
| Molecular Structure: | 
|
| Hazard Symbols: |  T:Toxic; |
| Risk Codes: | R22:; R45:; |
| Safety Description: | S45:; S53:; |
| Company: | Hubei yuancheng saichuang technology co.,limited [ China ] |
| Contact: | Dora |
| Tel: | 0086-027-50755989 |
| Fax: | 0086-027-50755989 |
| Email: | amy@chembj.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
